Page last updated: 2024-08-23

amikacin and azlocillin

amikacin has been researched along with azlocillin in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-199034 (85.00)18.7374
1990's3 (7.50)18.2507
2000's2 (5.00)29.6817
2010's1 (2.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Daschner, FD; Langmaack, H; Steffens, A1
Dudley, MN; Zinner, SH1
Blaser, J1
Bodunkova, LE; Ivanitskaia, LP; Kudinova, MK; Samoĭlova, LN; Viadro, MM1
Arnow, P; Edlin, B; Flaherty, JP; George, D; O'Keefe, P; Waitley, D; Weinstein, RA1
Benn, R; Benson, W; Date, L; Gibson, J; Iland, H; Joshua, DE; Kronenberg, H; Vincent, PC; Wilson, A; Young, GA1
Angelini, A; Betti, S; D'Antonio, D; Dell'Isola, M; di Girolamo, A; Dragani, A; Fioritoni, G; Iacone, A; Piccolomini, R1
Calandra, T; Gaya, H; Glauser, MP; Klastersky, J; Meunier, F; Zinner, SH1
Bayer, AS; Kim, KS1
Beaufils, F; Bingen, E; Guihaire, E; Lambert-Zechovsky, N; Mercier, JC; Nancy, C1
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T1
Blaser, J; Zinner, SH1
Bamberger, DM; Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR1
Bébéar, C; Fourche, J; Mazaud, C; Mormede, M; Texier-Maugein, J1
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR2
Almela, M; Carreras, E; Grañena, A; Jiménez de Anta, MT; Marín, P; Rozman, C; Valls, A1
Fasching, CE; Gerding, DN; Peterson, LR1
Gaya, H; Glauser, MP; Klastersky, J; Schimpff, SC; Zinner, SH1
Johnson, DE; Thompson, B1
Antonioni, M; De Cristofaro, A; Mergoni, M; Stocchetti, N; Zuccoli, P1
Blaser, J; Dudley, M; Zinner, SH1
Klastersky, J1
Gilly, R; Grenier, B1
Bricaire, F; Bure, A; Humbert, G; Vachon, F; Vilde, JL1
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ1
Bernard, C; Gaya, H; Klastersky, J; Ryff, JC; Zinner, SH1
Balischewski, B; Kiessig, R; Köditz, H; Thal, W1
Jacquillat, C; Khayat, D; Maral, J1
Boulton Jones, JM; Gribben, J; Leung, AC; Sleigh, JD1
Gerding, DN; Moody, JA; Peterson, LR1
Barry, AL; Gavan, TL; Jones, RN; Thornsberry, C1
Pickering, LK; Rutherford, I1
Baltch, AL; Conroy, JV; Hammer, MC; Matzkowitz, AJ; Smith, RP; Sutphen, NT1
Burghoffer, B; Daguet, GL; Petit, JC; Richard, G1
Shah, PM; Siegel, K; Stille, W1
Ferrer, NF; Hernández, ME; Ramos, MJ1

Trials

9 trial(s) available for amikacin and azlocillin

ArticleYear
Gram-positive bacteraemia in granulocytopenic cancer patients.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:5

    Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Sepsis

1990
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
    The American journal of medicine, 1989, Nov-30, Volume: 87, Issue:5A

    Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Random Allocation

1989
A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.
    Australian and New Zealand journal of medicine, 1989, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Floxacillin; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Randomized Controlled Trials as Topic; Remission Induction; Therapeutic Equivalency

1989
Evaluation of azlocillin-amikacin combination for empirical therapy of infection in febrile neutropenic patients.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:6

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neutropenia

1989
Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.
    The New England journal of medicine, 1987, 12-31, Volume: 317, Issue:27

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Ceftazidime; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Neoplasms; Prognosis; Random Allocation; Regression Analysis; Sepsis

1987
Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Cefotaxime; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Male; Middle Aged; Penicillins; Prospective Studies; Random Allocation; Regression Analysis; Sepsis; Ticarcillin

1986
Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:4

    Topics: Adult; Aged; Amikacin; Azlocillin; Bacterial Infections; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Random Allocation

1987
In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:4

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella; Klebsiella Infections; Mice; Mice, Inbred BALB C; Penicillins; Pseudomonas aeruginosa; Serratia; Staphylococcus aureus

1981
[Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)].
    Presse medicale (Paris, France : 1983), 1984, Mar-29, Volume: 13, Issue:13

    Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neoplasms; Penicillins; Ticarcillin

1984

Other Studies

31 other study(ies) available for amikacin and azlocillin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Chemotherapy, 1979, Volume: 25, Issue:5

    Topics: Amikacin; Aminoglycosides; Azlocillin; Drug Synergism; Escherichia coli; Gentamicins; Imidazolidines; Klebsiella pneumoniae; Netilmicin; Penicillin Resistance; Penicillins; Proteus; Pseudomonas aeruginosa; Sisomicin; Tobramycin

1979
Single daily dosing of amikacin in an in-vitro model.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl C

    Topics: Amikacin; Azlocillin; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1991
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
    Scandinavian journal of infectious diseases. Supplementum, 1990, Volume: 74

    Topics: Amikacin; Azlocillin; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus

1990
[Combined chemotherapy of experimental infection in neutropenia].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1989, Volume: 34, Issue:5

    Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Immune Tolerance; Klebsiella Infections; Mice; Neutropenia; Opportunistic Infections; Pseudomonas Infections

1989
In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
    Chemotherapy, 1986, Volume: 32, Issue:4

    Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Kanamycin; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Time Factors

1986
[Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
    Presse medicale (Paris, France : 1983), 1986, Dec-20, Volume: 15, Issue:46

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Ticarcillin

1986
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 1986, Volume: 5, Issue:1

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin

1986
In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl A

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Ceftazidime; Drug Combinations; Drug Synergism; Escherichia coli; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Thienamycins

1986
Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:1

    Topics: Amikacin; Animals; Azlocillin; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits

1986
[Bacteriostatic activity of azlocillin, gentamycin, amikacin singly or in combination on 200 strains of Pseudomonas aeruginosa].
    Pathologie-biologie, 1986, Volume: 34, Issue:5

    Topics: Amikacin; Azlocillin; Drug Combinations; Drug Synergism; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa

1986
In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
    Diagnostic microbiology and infectious disease, 1987, Volume: 7, Issue:2

    Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Kinetics; Neutropenia; Penicillin G; Rabbits; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae

1987
[Microorganisms isolated in 54 patients receiving bone marrow transplants and evaluation of their sensitivity to antimicrobial agents].
    Medicina clinica, 1987, Nov-28, Volume: 89, Issue:18

    Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Bone Marrow Transplantation; Cefotaxime; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance

1987
Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.
    The American journal of medicine, 1987, Apr-27, Volume: 82, Issue:4A

    Topics: Amikacin; Animals; Azlocillin; Bacterial Infections; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Evaluation, Preclinical; Female; Gram-Negative Bacteria; Penicillin Resistance; Rabbits

1987
Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    The American journal of medicine, 1986, May-30, Volume: 80, Issue:5C

    Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Drug Therapy, Combination; Female; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Penicillins; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Ticarcillin

1986
In vitro models for the study of combination antibiotic therapy in neutropenic patients.
    The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B

    Topics: Agranulocytosis; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Carbenicillin; Cefazolin; Cephalothin; Drug Therapy, Combination; Gentamicins; Humans; Models, Biological; Neutropenia; Pseudomonas Infections; Risk

1986
Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
    Archives of internal medicine, 1982, Oct-25, Volume: 142, Issue:11

    Topics: Amikacin; Azlocillin; Bacterial Infections; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Piperacillin

1982
[Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
    Presse medicale (Paris, France : 1983), 1984, Mar-29, Volume: 13, Issue:13

    Topics: Adolescent; Amikacin; Azlocillin; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sputum

1984
[Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
    Presse medicale (Paris, France : 1983), 1984, Mar-29, Volume: 13, Issue:13

    Topics: Adolescent; Adult; Aged; Amikacin; Azlocillin; Drug Therapy, Combination; Female; Humans; Male; Meningitis; Middle Aged; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

1984
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 1980, Volume: 6, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin

1980
[Antibacterial activities of amicacin, azlocillin and cefotaxim in bronchial secretion and serum of children].
    Kinderarztliche Praxis, 1983, Volume: 51, Issue:9

    Topics: Amikacin; Anti-Infective Agents; Azlocillin; Bronchi; Cefotaxime; Child; Humans; Kanamycin; Penicillins

1983
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:5

    Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Cefoxitin; Ceftizoxime; Disease Models, Animal; Drug Combinations; Female; Hydrogen-Ion Concentration; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillins; Protein Binding; Pseudomonas Infections; Rabbits

1984
Successful treatment of multiresistant pseudomonas peritonitis with combination of azlocillin and amikacin.
    Scottish medical journal, 1983, Volume: 28, Issue:1

    Topics: Amikacin; Azlocillin; Female; Humans; Kanamycin; Middle Aged; Penicillin Resistance; Penicillins; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections

1983
In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Bacteria; Cephalosporins; Drug Interactions; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa

1984
In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
    Cleveland Clinic quarterly, 1980,Winter, Volume: 47, Issue:4

    Topics: Amikacin; Ampicillin; Azlocillin; Bacteria; Carbenicillin; Gentamicins; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin

1980
Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
    The Journal of pharmacology and experimental therapeutics, 1981, Volume: 217, Issue:2

    Topics: Amdinocillin; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Gentamicins; Mezlocillin; Netilmicin; Penicillins; Piperacillin; Time Factors; Tobramycin

1981
In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:4

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin

1982
[Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Pathologie-biologie, 1982, Volume: 30, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Cefsulodin; Ceftazidime; Cephalosporins; Drug Synergism; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Ticarcillin; Tobramycin

1982
[Clinical experience with non-specific broad-spectrum antibacterial chemotherapy (author's transl)].
    Infection, 1982, Volume: 10, Issue:2

    Topics: Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Cefoxitin; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillins; Tobramycin

1982
[Azlocillin plus amikacin: an alternative therapy for sepsis caused by resistant staphylococci?].
    Revista panamericana de salud publica = Pan American journal of public health, 2004, Volume: 16, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Models, Theoretical; Retrospective Studies; Sepsis; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus

2004